eXoZymes selects Curia as commercial-scale manufacturing partner for NCT - EXOZ News | RallieseXoZymes selects Curia as commercial-scale manufacturing partner for NCT
E
EXOZ• Curia to support NCT manufacturing scale-up
- Exozymes entered an agreement with Curia to transfer and scale up manufacturing for N-trans-caffeoyltyramine (NCT).
- Program set to start in Q4 2026, targeting a technical roadmap for larger-scale production in 2027.
- Curia to run scale-up work at facilities in León, Spain, and Rozzano, Italy.
- Collaboration supports planned commercial launch preparation, including customer qualification and future supply agreements for NCT.
•
